Skip to content

Effects of SIT Combined with Remote Ischemic Preconditioning on Vascular Function in Young Women with Masked Obesity

Effects of Sprint Interval Training Combined with Remote Ischemic Preconditioning on Vascular Function in Young Women with Masked Obesity

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06664281
Enrollment
44
Registered
2024-10-29
Start date
2023-02-28
Completion date
2023-12-30
Last updated
2024-10-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vascular Function

Keywords

Sprint Interval Training, Masked Obesity, Young Women, Ischemic Preconditioning, Vascular Function

Brief summary

Comparison of the effects of combined Sprint Interval Training (SIT) with Remote Ischemic Preconditioning (RIPC) and SIT on vascular function in young women with masked obesity.

Detailed description

This is a randomized clinical trial of single-blind with 3 arms (control group, SIT group and SIT with RIPC group), in which a pre-treatment-posttest design has been used.

Interventions

BEHAVIORALSIT

sprint interval training

BEHAVIORALSIT combined RIPC

sprint interval training combined with remote ischemic preconditioning

Sponsors

Beijing Sport University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
Yes

Inclusion criteria

* Females aged between 18 and 30 years; * BMI within the normal range (18.5~24.9 kg/m²), BF% \> 30%; * Participants with no clinically diagnosed contraindications for exercise, in good health, and not engaged in regular exercise, as determined by the health and physical activity questionnaire (based on the American College of Sports Medicine's guidelines for exercise testing and prescription).

Exclusion criteria

* History of cardiovascular diseases, including coronary heart disease, stroke, or peripheral arterial disease diagnosed through vascular imaging techniques; * Currently participating in other intervention studies, including dietary, nutritional, or psychological education programs; * Those with regular professional training; * Musculoskeletal disorders that make long-term exercise interventions unsuitable.

Design outcomes

Primary

MeasureTime frameDescription
Intima-Media Thickness (IMT)8 weeksChanges in Intima media thickness before and after intervention.
Flow-Mediated Dilation (FMD)8 weeksChanges in Flow-mediated dilation before and after Intervention. Brachial artery flow-mediated dilation (FMD) was measured by the UNEXEF high-resolution ultrasound vascular endothelial function analyzer.

Secondary

MeasureTime frameDescription
Blood Pressure (BP)8 weeksChanges in blood pressure before and after intervention. Including systolic and diastolic blood pressure.
Body Composition Indicator8 weeksChanges in Body composition indicators before and after Intervention. Including body fat percentage (BF%).
Maximum Oxygen Uptake (VO2max)8 weeksChanges in maximum oxygen uptake before and after Intervention.
Nitric Oxide (NO)8 weeksChanges in concentration of nitric oxide before and after Intervention.
Human Morphometric i Indicators8 weeksChanges in Human morphometric indicators before and after Intervention. Including height, weight, waist circumference, hip circumference, and body mass index (BMI). BMI was calculated based on the measured height and weight using the formula: BMI = weight/height² (kg/m²).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026